脑出血患者中的中性粒细胞胞外诱捕网
这项前瞻性单中心队列研究纳入50例症状发作24小时内的自发性脑出血患者(平均72岁,86%幕上,血肿中位16 ml,水肿中位11 ml),在入院时、第2/3天、第6天检测血浆NET组分(H3Cit-DNA、MPO-DNA、cfDNA)及DNase活性。入院时NETs水平高于健康对照且DNase活性更低;6天内NET组分持续升高、DNase活性下降,NET轨迹与血肿体积、血肿周围水肿体积及临床结局相关。结论提示NETs可能参与脑出血后继发性损伤,但研究为相关性观察,需进一步验证功能作用。
要点
- 脑出血患者入院时H3Cit-DNA、cfDNA高于健康对照(p<0.001),DNase活性低于对照(p=0.012)。
- 发病6天内H3Cit-DNA从基线中位6.0 ng/ml升至12.0 ng/ml,MPO-DNA从1.4升至2.6 ng/ml,cfDNA从115升至137 ng/ml(均p<0.001)。
- 同期DNase活性从85%降至66%(p<0.001),NETs升高与DNase活性下降同步出现。
- NET轨迹与血肿体积、血肿周围水肿体积及临床结局指标相关,但原文未给出具体相关系数或预测阈值。
- 该研究为单中心、50例、观察性队列,NETs尚不能作为床旁决策或治疗靶点的依据。
适用人群与场景
- 症状发作24小时内的自发性脑出血患者,前瞻性单中心队列纳入50例,平均年龄72岁,86%为幕上出血,血肿中位体积16 ml(IQR 5.8-38),血肿周围水肿中位体积11 ml(IQR 5-26)。
- 原文未提及排除标准及院前/急诊/ICU具体场景分层。
诊断标准与关键阈值
- 原文未提及诊断标准或NETs相关临床决策阈值。
处置流程与药物剂量
- 原文未提及基于NETs的处置流程或药物剂量。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性单中心队列研究,样本量50例,无多中心数据。
- 主要观察:入院时NETs可检出且高于健康对照(H3Cit-DNA p<0.001;cfDNA p<0.001),DNase活性低于对照(p=0.012)。
- 时间趋势:6天内H3Cit-DNA(基线中位6.0 ng/ml [IQR 1.4-9.5] vs 第6天12.0 ng/ml [IQR 5.7-19.0],p<0.001)、MPO-DNA(1.4 ng/ml [IQR 0.59-2.2] vs 2.6 ng/ml [IQR 1.4-3.4],p<0.001)、cfDNA(115 ng/ml [IQR 106-125] vs 137 ng/ml [IQR 127-152],p<0.001
- 原文未提及关键次要终点及不良事件的具体数据。
证据类型、等级与局限
- 证据类型:前瞻性单中心观察性队列研究。
- 局限:单中心、样本量小(50例)、观察性设计,仅显示相关性,原文结论明确需未来研究评估NETs的功能作用。
对床旁实践的改变
- 该内容不改变当前急诊/ICU对脑出血的常规处置;NETs及DNase活性目前仅为研究性生物标志物,不能用于床旁风险分层或治疗决策。
- 适用人群为症状发作24小时内的自发性脑出血患者(研究纳入人群),原文未提及其他适用或不适用人群。
- 常见陷阱:将NETs与结局的相关性误读为因果关系或决策阈值;原文未提供任何可用于临床的cut-off值。
指南或共识出处
- 原文未提及指南或共识名称;文献来源为Neurocrit Care。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) is a subtype of stroke frequently resulting in severe disability. Secondary mechanisms after ICH include neuroinflammation and development of perihematomal edema. Neutrophil extracellular traps (NETs) mediate infection defense and are involved in disease processes affecting the nervous system, including immunothrombosis and blood-brain barrier disruption. We aimed to assess NETs in ICH and their potential contribution to outcome measures.
METHODS: We conducted a prospective, single-center cohort study recruiting patients with ICH within 24 h after symptom onset and collected clinical, laboratory, imaging, and 3-month outcome data. NET components [citrullinated histone H3[H3Cit]-DNA complexes and myeloperoxidase (MPO)-DNA complexes, cell-free DNA (cfDNA)] and DNase activity were measured in plasma collected on admission, on day 2/3, and on day 6 (± 1 day) after admission. We assessed ICH volume and perihematomal edema (PHE) semiquantitatively.
RESULTS: We enrolled 50 patients with ICH (mean age 72 years) with mainly supratentorial ICH (86%), a median ICH volume of 16 ml [interquartile range (IQR) 5.8-38], and a median PHE volume of 11 ml (IQR 5-26). Compared with healthy controls, NETs were detectable in patients with ICH on admission at higher levels (H3Ccit-DNA, p < 0.001; cfDNA, p < 0.001) together with lower DNase activity (p = 0.012). During the first 6 days after ICH, we observed an increase of NET components H3Cit-DNA (baseline, median 6.0 ng/ml [IQR 1.4-9.5] vs. day 6, 12.0 ng/ml [IQR 5.7 vs. 19.0], p < 0.001), MPO-DNA (1.4 ng/ml [IQR 0.59-2.2] vs. 2.6 ng/ml [IQR 1.4-3.4], p < 0.001) and cfDNA (115 ng/ml [IQR 106-125] vs. 137 ng/ml [IQR 127-152], p < 0.001), and a decline in DNase activity (median 85% [IQR 66-102] vs. 66% [IQR 59-80], p < 0.001). NET trajectories correlated with imaging outcomes (ICH volume, PHE volume) and clinical outcome measures.
CONCLUSIONS: Increasing NETs and a decrease in DNase activity were observed during the early course after ICH onset and correlated with imaging and clinical outcomes. Future studies should evaluate the functional role of NETs in patients with ICH.
参考来源
- Gabor L, Zalghout S, Martinod K, et al. Neutrophil Extracellular Traps in Patients with Intracerebral Hemorrhage. Neurocrit Care. 2026. PMID: 42406306. doi:10.1007/s12028-026-02577-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。